Life Sciences Accounting & Reporting Europe. - Europe/London
- Ian Bishop - Group Finance - Head of Accounting, Consolidation & External Reporting, Roche
Update on Non-GAAP items:
Business restructuring
Acquisition-Related
New non-GAAP categories companies
Comment letters trends
FASB, Including Technical Updates:
- Segment reporting
Disaggregation of the Income Statement
Derivative Refinements impacting R&D Arrangements
Accounting for Software and Related Disclosure
Environmental Credits
Grant Accounting
Interim Reporting – Narrow Improvements
Technical Update: Intangibles Research Project, KPI Project
ESG Updates:
CSRD Double Materiality
EU Taxonomy Process
Third Party Service Providers
Accounting & Reporting Benchmarking:
Net Operating Cash Flow and Free Cash Flow Metric
License Payments and Cash Flow Classification
Capitalization of R&D Expense – US GAAP versus IFRS
Benchmark Topics:
Latest trends on GenAI’s impact on finance, including successful use cases in deploying AI
Talent Development and Retention in Finance
Other disclosure reporting practices
- Stephen Rivera - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
- Ian Bishop - Group Finance - Head of Accounting, Consolidation & External Reporting, Roche